Short-Term Testosterone Therapy Associated With VTE Risk in Men
For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism.
Hormone Replacement Therapy
Extended Estrogen Therapy Aids Late-Life Cognition
Longer use of estrogen hormone therapy is associated with higher cognitive status in late life.
Inaccuracies of Weight-Based Levothyroxine Dosing After Total Thyroidectomy
In patients with overweight or obesity who undergo total thyroidectomy, choosing the thyroid hormone replacement dose based on body weight is frequently inaccurate and could be responsible for prolongation of the titration period.
Effects of Estrogen-Only Treatment in Women With Prior Hysterectomy
For women aged 50 to 59 years with a history of bilateral oophorectomy, estrogen therapy may have beneficial effects in the long-term.
Effect of Hormone Therapy on Muscle Mass in Postmenopausal Women
Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.
Type and Timing of Menopausal Hormone Therapy May Affect Breast Cancer Risk
Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.
Bone Loss Likely After Prophylactic Bilateral Salpingo-Oophorectomy
Premenopausal women who undergo prophylactic bilateral salpingo-oophorectomy are especially prone to postoperative bone loss, which may be mitigated by hormone replacement therapy.
Estrogen Preparations Have Varying Effects on Heart Fat Accumulation in Early Menopausal Women
Exogenous estrogen preparations may have different effects on heart fat accumulation and development of coronary artery calcification in early menopausal women.
Testosterone Replacement Therapy May Increase Cardiovascular Risk
For aging men with low testosterone levels, testosterone replacement therapy may increase the risk of cardiovascular events, especially in the first two years of use.
Increase in HDL-C, Adiponectin Levels With Glucocorticoid Replacement Therapy
Glucocorticoid replacement therapy is associated with an increase in serum levels of adiponectin and high-density lipoprotein cholesterol.
